http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011250816-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661b3ea63e73acc96731eb73625b1bc2 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate | 2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a38da3b640a5e58d06313264caaec58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9228cab7cb2a462bfd176c024503317c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12f74d78743c8eaa24ab690fa032d7a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17b8c8c04fcbedd86324dbcdf7723a52 |
publicationDate | 2014-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2011250816-B2 |
titleOfInvention | Compositions and methods for inhibiting expression of the HAMP gene |
abstract | The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the HAMP gene (HAMP gene), comprising an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of the HAMP gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by HAMP gene expression and the expression of the HAMP gene using the pharmaceutical composition. |
priorityDate | 2006-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 339.